Study guide

2.1 Patient History & Systemic Risk Factors

ABWM Certified Wound Specialist CWS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 About the ABWM CWS Exam 1.2 How to Use This Study Guide & Blueprint Strategy

2 Chapter 2: Comprehensive Patient & Wound Assessment

2.1 Patient History & Systemic Risk Factors 2.2 Physical Examination & Anatomical Wound Classification 2.3 Quantitative Wound Measurement & Documentation 2.4 Bioburden & Infection Assessment

3 Chapter 3: Vascular Assessment & Diagnostic Testing

Section 3.1: Ankle-Brachial Index (ABI) & Toe-Brachial Index (TBI) Interpretation Section 3.2: Advanced Vascular Diagnostics Section 3.3: Neuropathic & Sensory Assessment

4 Chapter 4: Laboratory, Imaging & Diagnostic Approaches

Section 4.1: Laboratory Evaluation in Wound Care Section 4.2: Imaging Modalities for Wounds & Bone Section 4.3: Differential Diagnosis of Recalcitrant & Atypical Wounds

5 Chapter 5: Physiology of Wound Healing & Tissue Repair

5.1 Hemostasis & Inflammatory Phase Dynamics 5.2 Proliferative & Remodeling Phases 5.3 Growth Factors & Extracellular Matrix (ECM)

6 Chapter 6: Biofilm Biology & Wound Bed Preparation

6.1 Biofilm Pathophysiology & Management Strategies 6.2 TIME Framework & Wound Bed Preparation 6.3 Moisture Balance & Exudate Management

7 Chapter 7: Pressure Injuries & Moisture-Associated Skin Damage

7.1 Pressure Injury Pathophysiology & NPIAP Staging 7.2 Risk Assessment Tools & Support Surface Selection 7.3 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis

8 Chapter 8: Lower Extremity Ulcers (Venous, Arterial & Mixed)

Section 8.1: Venous Leg Ulcers & CEAP Classification Section 8.2: Arterial Ulcers & Peripheral Artery Disease Section 8.3: Mixed Venous-Arterial Ulcers & Lymphedema

9 Chapter 9: Diabetic Foot Ulcers & Neuropathic Wounds

Section 9.1: Diabetic Foot Ulcer Pathophysiology & Classification Section 9.2: Diabetic Foot Infection & Osteomyelitis Management

10 Chapter 10: Thermal Injuries, Surgical Wounds & Special Etiologies

Section 10.1: Burn Injuries & Thermal Damage Section 10.2: Surgical Wounds, Dehisced Incisions & Fistulas Section 10.3: Dermatological, Pediatric & Miscellaneous Wound Types

11 Chapter 11: Debridement & Topically Applied Therapies

Section 11.1: Debridement Modalities & Selection Section 11.2: Wound Dressing Selection & Categories Section 11.3: Topical Antimicrobial Agents & Antiseptics

12 Chapter 12: Compression Therapy & Advanced Off-Loading

Section 12.1: Compression Therapy Modalities & Science Section 12.2: Off-Loading Devices & Biomechanical Protection

13 Chapter 13: Advanced & Adjunctive Wound Therapies

Section 13.1: Negative Pressure Wound Therapy (NPWT) Section 13.2: HBOT, Biophysical Agents & Advanced Biologics Section 13.3: Systemic Nutrition, Hydration & Pain Management

14 Chapter 14: Professional Practice, Reimbursement & Interprofessional Care

14.1 Professional Ethics, Scope of Practice & ABWM Guidelines 14.2 Documentation, Coding & Reimbursement Standards 14.3 Interprofessional Team Roles & Quality Improvement

2.1 Patient History & Systemic Risk Factors

Key Takeaways Explain This Topic AI

Systemic conditions such as uncontrolled diabetes mellitus (HbA1c > 7.0%), end-stage renal disease (ESRD), and severe protein-calorie malnutrition profoundly delay tissue healing by compromising microvascular perfusion, immune response, and extracellular matrix synthesis.

Cigarette smoking and nicotine exposure severely impair tissue repair through endothelin-mediated vasoconstriction, elevated carboxyhemoglobin levels, reduced transcutaneous oxygen tension (TcPO2), and impaired collagen deposition.

Exogenous corticosteroids inhibit all phases of wound healing by suppressing macrophage recruitment, blunting inflammatory cytokine release, and reducing TGF-beta production—an effect that can be partially reversed with topical or systemic Vitamin A.

Comprehensive functional assessment (ADLs/IADLs) and evaluation of social determinants of health (SDOH) are essential for establishing offloading adherence, dressing management feasibility, and caregiver support capacity.

Last updated: July 2026

Patient History & Systemic Risk Factors

Cutaneous wound healing is a dynamic, energy-intensive physiological process that depends fundamentally on the patient's overall systemic health. While local wound bed preparation and topical dressing selection are essential components of care, advanced wound management fails when underlying systemic pathologies remain unrecognized or unmanaged. A comprehensive patient history and systemic risk assessment allow the Certified Wound Specialist (CWS) to identify metabolic, vascular, immunological, nutritional, pharmaceutical, and psychosocial barriers to repair. By addressing these root systemic drivers, clinicians convert non-healing, chronic wounds into biologically active, progressing repair environments.

1. Systemic Pathophysiological Factors Impairing Tissue Healing

Systemic diseases disrupt normal tissue repair by impairing cellular recruitment, blunting oxygen delivery, altering extracellular matrix (ECM) synthesis, or suppressing immune surveillance. Identifying these factors during initial patient history taking is critical.

Diabetes Mellitus & Glycemic Control

Uncontrolled diabetes mellitus is one of the most prevalent systemic drivers of chronic non-healing wounds. Persistent hyperglycemia ( > 180 mg/dL >180\text{ mg/dL} > 180 mg/dL ) causes systemic microvascular and macrovascular disease, peripheral neuropathy, and immune dysregulation:

Advanced Glycation End-Products (AGEs): Non-enzymatic glycation of long-lived structural proteins (such as collagen) alters ECM architecture, stiffens vessel walls, and impairs cell-matrix interactions.

Impaired Leukocyte Function: Hyperglycemia blunts neutrophil chemotaxis, phagocytosis, and intracellular bacterial killing, predisposing the patient to rapid wound bioburden expansion and soft tissue infection.

Microvascular Dysfunction: Thickening of the capillary basement membrane impairs nutrient and gas exchange at the tissue level.

Glycemic Target: Clinical guidelines recommend maintaining glycated hemoglobin (HbA1c) below 7.0% (or < 8.0 % <8.0\% < 8.0% in complex elderly patients with limited life expectancy) to optimize tissue healing velocity.

Cigarette Smoking & Nicotine Exposure

Tobacco smoking introduces over 4,000 toxic compounds that directly impede every phase of wound repair:

Nicotine-Induced Vasoconstriction: Nicotine stimulates sympathetic catecholamine release and endothelin-1 secretion, causing potent peripheral vasoconstriction. A single cigarette reduces cutaneous blood flow by up to 40% for over 50 minutes.

Tissue Hypoxia: Carbon monoxide binds to hemoglobin with an affinity 200 times higher than oxygen, forming carboxyhemoglobin. This shifts the oxygen-hemoglobin dissociation curve to the left (Haldane effect), reducing oxygen delivery to peripheral tissues and severely depressing transcutaneous oxygen tension (TcPO2).

Platelet Aggregation & Fibrosis: Smoking increases blood viscosity and platelet reactivity, promoting microvascular thrombosis and blunting inflammatory cell migration.

Immunosuppression & Autoimmune Disease

Host defense mechanisms are essential for clearing devitalized tissue and pathogens during the inflammatory phase:

Primary & Secondary Immunodeficiencies: HIV/AIDS, organ transplantation, and hematological malignancies reduce functional CD4+ T-lymphocytes and neutrophils.

Autoimmune Pathologies: Rheumatoid arthritis, systemic lupus erythematosus (SLE), and vasculitis cause immune-complex deposition in dermal microvessels, leading to painful necrotic ulcers (vasculitic ulcers) that fail to respond to standard moist wound healing without systemic immunosuppressive modulation.

End-Stage Renal Disease (ESRD) & Uremia

Patients with end-stage renal disease requiring hemodialysis exhibit multiple compounding wound healing deficits:

Uremic Toxins: Accumulated uremic waste products inhibit fibroblast proliferation, endothelial cell sprouting, and keratinocyte re-epithelialization.

Calciphylaxis (Calcific Uremic Arteriolopathy): A life-threatening vascular complication seen primarily in ESRD, characterized by medial calcification, intima hyperplasia, and microvascular thrombosis of dermal arterioles. It results in extremely painful, violaceous retiform purpura that rapidly progresses to extensive ischemic cutaneous necrosis.

Chronic Anemia & Fluid Overload: Reduced erythropoietin production leads to profound anemia and diminished tissue oxygenation, while peripheral edema increases diffusion distance for nutrients.

Malnutrition & Nutritional Deficiencies

Tissue repair requires significant caloric, protein, and micronutrient expenditure. Protein-calorie malnutrition leads to wound dehiscence, delayed granulation, and heightened infection risk:

Protein Requirements: Patients with active chronic wounds require 1.2 to 1.5 g/kg/day of protein (up to 2.0 g/kg/day for extensive exudative wounds, severe pressure injuries, or burns) to support cell proliferation and matrix synthesis.

Biochemical Markers: Serum albumin ( < 3.5 g/dL <3.5\text{ g/dL} < 3.5 g/dL ) reflects chronic protein depletion, visceral protein stores, and systemic inflammation (negative acute-phase reactant). Prealbumin (transthyretin) has a short half-life of 2 to 3 days, making it the most sensitive laboratory marker ( < 15 mg/dL <15\text{ mg/dL} < 15 mg/dL ) for acute changes in nutritional status and adequacy of refeeding.

Key Micronutrients:

Vitamin C (Ascorbic Acid): Essential cofactor for lysyl and prolyl hydroxylase, enzymes responsible for collagen triple-helix cross-linking. Deficiency (scurvy) results in fragile, un-crosslinked collagen and wound breakdown.

Zinc: Required for cell division, DNA/RNA polymerase activity, and matrix metalloproteinase (MMP) function. Deficiency impairs re-epithelialization.

Vitamin A: Essential for epithelial differentiation and macrophage activation.

2. Pharmaceutical Impacts on Tissue Repair

A thorough medication reconciliation is essential to identify pharmacological agents that interfere with inflammation, coagulation, or cellular proliferation.

Medication Class Primary Representative Agents Biological Mechanism Impairing Healing Clinical Management / Countermeasures

Corticosteroids Prednisone, Dexamethasone, Methylprednisolone Inhibits phospholipase A2; blunts macrophage recruitment; suppresses TGF- β \beta β and PDGF; decreases collagen synthesis and wound contraction. Administer topical or systemic Vitamin A (10,000–25,000 IU/day orally or topical application) to restore lysosomal membrane labilization and macrophage influx.

Anticoagulants & Antiplatelets Warfarin, Heparin, Enoxaparin, Apixaban, Aspirin, Clopidogrel Prolongs bleeding time; increases risk of intra-wound hematoma formation; blunts early fibrin clot matrix establishment. Warfarin can trigger protein C depletion necrosis. Carefully coordinate peri-procedural hold times prior to sharp debridement; utilize topical hemostatic agents (silver nitrate, calcium alginate, collagen matrices) locally.

Antineoplastic Agents Methotrexate, Doxorubicin, Cyclophosphamide, 5-Fluorouracil Cytotoxic inhibition of rapidly dividing cells; causes severe neutropenia, anemia, and thrombocytopenia; blunts fibroblast proliferation. Delay elective wound procedures or surgical reconstruction until chemotherapy cycles complete and absolute neutrophil count (ANC) recovers ( > 1 , 000 / μ L >1,000/\mu\text{L} > 1 , 000/ μ L ).

Immunosuppressants Tacrolimus, Cyclosporine, Mycophenolate mofetil Suppresses T-cell signaling and interleukin-2 synthesis; delays inflammatory phase resolution and tissue remodeling. Monitor for subtle signs of local bioburden expansion; maintain strict aseptic technique and moist wound healing environment.

3. Functional & Psychosocial Assessment

A wound does not exist in isolation; it affects and is affected by the patient's physical functional capacity and social ecosystem.

Functional Capacity & Activities of Daily Living (ADLs)

Evaluating basic ADLs (bathing, dressing, toileting, transferring, feeding) and Instrumental ADLs (meal preparation, housekeeping, medication management, transportation) provides vital context:

Mobility & Offloading Capability: A patient with severe hip osteoarthritis or hemiplegia may be physically unable to execute weight shifts every 15 minutes or apply removable cast walkers independently.

Manual Dexterity & Vision: Advanced diabetic retinopathy or severe rheumatoid hand deformities prevent patients from performing complex dressing changes independently.

Psychosocial Determinants & Social Determinants of Health (SDOH)

Unaddressed psychosocial barriers frequently manifest as clinical treatment failure or perceived "non-compliance":

Financial & Insurance Constraints: Inability to afford advanced wound care dressings, compression wraps, or negative pressure wound therapy (NPWT) supplies.

Cognitive Status & Health Literacy: Dementia or executive dysfunction impairs adherence to offloading schedules, dietary plans, and dressing protocols. Instructions must be simplified and provided to designated caregivers.

Living Environment & Support System: Unsanitary living conditions, lack of running water, housing instability, or social isolation severely elevate infection risk and compromise home care execution.